| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Otonomy Inc (NASDAQ: OTIC)
OTIC Technical Analysis
5
| As on 11th Apr 2023 OTIC STOCK Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.80 & Strong Sell for SHORT-TERM with Stoploss of 2.11 we also expect STOCK to react on Following IMPORTANT LEVELS. |
OTICSTOCK Price
| Open | 0.02 | Change | Price | % |
| High | 0.02 | 1 Day | -0.11 | -91.67 |
| Low | 0.01 | 1 Week | -0.11 | -91.67 |
| Close | 0.01 | 1 Month | -0.10 | -90.91 |
| Volume | 1943468 | 1 Year | -1.85 | -99.46 |
| 52 Week High 2.51 | 52 Week Low 0.07 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| NVDA | 146.67 | 0.53% |
| AKTS | 0.10 | 11.11% |
| WORX | 2.12 | 116.33% |
| QUBT | 4.76 | 29.35% |
| LMDX | 0.02 | 0.00% |
| SMCI | 29.70 | 5.06% |
| MSTR | 397.28 | -16.16% |
| MARA | 23.81 | 22.17% |
| CRNC | 5.83 | 106.74% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| OTIC Daily Charts |
OTIC Intraday Charts |
Whats New @ Bazaartrend |
OTIC Free Analysis |
|
|
OTIC Important Levels Intraday
| RESISTANCE | 0.03 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
| SUPPORT | -0.01 |
OTIC Forecast November 2024
| 4th UP Forecast | 0.93 |
| 3rd UP Forecast | 0.64 |
| 2nd UP Forecast | 0.45 |
| 1st UP Forecast | 0.27 |
| 1st DOWN Forecast | -0.25 |
| 2nd DOWN Forecast | -0.43 |
| 3rd DOWN Forecast | -0.62 |
| 4th DOWN Forecast | -0.91 |
OTIC Weekly Forecast
| 4th UP Forecast | 0.49 |
| 3rd UP Forecast | 0.34 |
| 2nd UP Forecast | 0.24 |
| 1st UP Forecast | 0.15 |
| 1st DOWN Forecast | -0.13 |
| 2nd DOWN Forecast | -0.22 |
| 3rd DOWN Forecast | -0.32 |
| 4th DOWN Forecast | -0.47 |
OTIC Forecast2024
| 4th UP Forecast | 4.98 |
| 3rd UP Forecast | 3.39 |
| 2nd UP Forecast | 2.4 |
| 1st UP Forecast | 1.42 |
| 1st DOWN Forecast | -1.4 |
| 2nd DOWN Forecast | -2.38 |
| 3rd DOWN Forecast | -3.37 |
| 4th DOWN Forecast | -4.96 |
Otonomy Inc ( NASDAQ USA Symbol : OTIC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
OTIC Business Profile
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTIPRIO, a ciprofloxacin otic suspension for use during tympanostomy tube placement surgery in pediatric patients. It also develops OTIVIDEX, a sustained-exposure formulation of the steroid dexamethasone that has completed Phase III clinical trial for the treatment of Ménière's disease; OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which has completed Phase I/II clinical trial to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurotrophic factor that is in Phase I/II clinical trial for the repair of cochlear synaptopathy and the treatment of speech-in-noise hearing difficulties. In addition, the company develops OTO-510, an otoprotectant for the prevention of cisplatin-induced hearing loss; OTO-825, a gene therapy for the treatment of congenital hearing loss; and OTO-6XX induces hair cell repair and regeneration for the treatment of severe hearing loss. The company has license agreements with University of California and DURECT Corporation; and strategic collaboration with Applied Genetic Technologies Corporation to develop and commercialize gene therapy for congenital hearing loss. Otonomy, Inc. was incorporated in 2008 and is headquartered in San Diego, California. Address: 4796 Executive Drive, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service